Dassault Systèmes has lowered its revenue growth forecast due to underperformance in its Life Sciences and CENTRIC PLM divisions, while aiming to leverage artificial intelligence advances by 2026.
- Dassault Systèmes reduced its annual revenue growth outlook to 4%–6%, down from the previous 6%–8%, following disappointing third-quarter results.
- The companys performance was impacted by weaker results in its Life Sciences division, which is critical for clients like Sanofi in drug development and clinical research.
- Workflow improvements in the pharmaceutical industry are expected as Dassault Systèmes plans to leverage artificial intelligence to enhance data quality by 2026.
Why It Matters
This revenue forecast adjustment reflects broader challenges within the technology sector and highlights the increasing importance of artificial intelligence in enhancing operational efficiencies, especially in critical industries like pharmaceuticals.